Mengze Lv

3.4k total citations · 3 hit papers
9 papers, 2.6k citations indexed

About

Mengze Lv is a scholar working on Immunology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Mengze Lv has authored 9 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 4 papers in Molecular Biology and 3 papers in Infectious Diseases. Recurrent topics in Mengze Lv's work include interferon and immune responses (7 papers), Immune Response and Inflammation (4 papers) and Inflammasome and immune disorders (4 papers). Mengze Lv is often cited by papers focused on interferon and immune responses (7 papers), Immune Response and Inflammation (4 papers) and Inflammasome and immune disorders (4 papers). Mengze Lv collaborates with scholars based in China, United States and Malaysia. Mengze Lv's co-authors include Zhengfan Jiang, Chenguang Wang, Xiaoming Wei, Rui Zhang, Yukun Guan, Miao Jing, Xiao‐Jun Huang, Xiao‐Dong Su, Yi Wan and Pengfei Gao and has published in prestigious journals such as Cell, Immunity and Molecular Cell.

In The Last Decade

Mengze Lv

9 papers receiving 2.6k citations

Hit Papers

Manganese is critical for antitumor immune responses via ... 2018 2026 2020 2023 2020 2018 2021 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mengze Lv China 9 1.7k 1.1k 689 445 345 9 2.6k
Yukun Guan United States 15 1.8k 1.0× 1.1k 1.0× 691 1.0× 484 1.1× 322 0.9× 31 2.7k
Tae Heung Kang South Korea 34 1.5k 0.9× 1.3k 1.1× 476 0.7× 133 0.3× 767 2.2× 81 2.9k
Eva M. Gálvez Spain 20 373 0.2× 586 0.5× 393 0.6× 300 0.7× 304 0.9× 60 1.7k
Yukihiko Aramaki Japan 29 761 0.4× 1.4k 1.2× 579 0.8× 82 0.2× 161 0.5× 129 2.7k
Plamen P. Christov United States 20 713 0.4× 986 0.9× 302 0.4× 187 0.4× 222 0.6× 51 1.8k
Fatemeh Rahbarizadeh Iran 32 687 0.4× 1.4k 1.2× 520 0.8× 109 0.2× 954 2.8× 132 2.8k
Guangsheng Du China 26 713 0.4× 687 0.6× 533 0.8× 110 0.2× 126 0.4× 56 1.9k
Masaharu Shin‐Ya Japan 24 672 0.4× 738 0.7× 264 0.4× 129 0.3× 299 0.9× 49 2.0k
Yijuan Zhang China 21 388 0.2× 907 0.8× 288 0.4× 111 0.2× 270 0.8× 53 1.7k

Countries citing papers authored by Mengze Lv

Since Specialization
Citations

This map shows the geographic impact of Mengze Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengze Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengze Lv more than expected).

Fields of papers citing papers by Mengze Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengze Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengze Lv. The network helps show where Mengze Lv may publish in the future.

Co-authorship network of co-authors of Mengze Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Mengze Lv. A scholar is included among the top collaborators of Mengze Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengze Lv. Mengze Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Zhang, Rui, Chenguang Wang, Yukun Guan, et al.. (2021). Manganese salts function as potent adjuvants. Cellular and Molecular Immunology. 18(5). 1222–1234. 218 indexed citations breakdown →
2.
Goc, Jérémy, Mengze Lv, Nicholas J. Bessman, et al.. (2021). Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancer. Cell. 184(19). 5015–5030.e16. 135 indexed citations
3.
Song, Yuan, Yonghao Liu, Yu Mei, et al.. (2020). Manganese enhances the antitumor function of CD8+ T cells by inducing type I interferon production. Cellular and Molecular Immunology. 18(6). 1571–1574. 61 indexed citations
4.
Lv, Mengze, Meixia Chen, Rui Zhang, et al.. (2020). Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy. Cell Research. 30(11). 966–979. 719 indexed citations breakdown →
5.
Ning, Xiaohan, Yutao Wang, Miao Jing, et al.. (2019). Apoptotic Caspases Suppress Type I Interferon Production via the Cleavage of cGAS, MAVS, and IRF3. Molecular Cell. 74(1). 19–31.e7. 251 indexed citations
6.
Wang, Chenguang, Rui Zhang, Xiaoming Wei, Mengze Lv, & Zhengfan Jiang. (2019). Metalloimmunology: The metal ion-controlled immunity. Advances in immunology. 145. 187–241. 229 indexed citations
7.
Wang, Chenguang, Yukun Guan, Mengze Lv, et al.. (2018). Manganese Increases the Sensitivity of the cGAS-STING Pathway for Double-Stranded DNA and Is Required for the Host Defense against DNA Viruses. Immunity. 48(4). 675–687.e7. 614 indexed citations breakdown →
8.
Wang, Yutao, Xiaohan Ning, Pengfei Gao, et al.. (2017). Inflammasome Activation Triggers Caspase-1-Mediated Cleavage of cGAS to Regulate Responses to DNA Virus Infection. Immunity. 46(3). 393–404. 212 indexed citations
9.
Fang, Run, Chenguang Wang, Mengze Lv, et al.. (2017). NEMO–IKKβ Are Essential for IRF3 and NF-κB Activation in the cGAS–STING Pathway. The Journal of Immunology. 199(9). 3222–3233. 180 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026